ImmunityBio, Inc. (NASDAQ: IBRX), a vertically integrated, commercial-stage immunotherapy company, today announced that based ...
In the 21st century, artificial intelligence (AI) has emerged as a valuable approach in data science and a growing influence in medical research, 4-6 with an accelerating pace of innovation. This ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果